1. Amgen Inc
2. AstraZeneca
3. Bayer AG
4. Bristol-Myers Squibb Company
5. Pfizer Inc
6. Novarts AG
7. Johnson & Johnson
8. Eli Lily Company
9. F. Hoffmann-la Roche Ltd
10. Seattle Genetics Inc
Published | Pages | Publisher | Report code |
---|---|---|---|
Feb 2022 | 172 | Renub Research | ASDR-597019 |
1. Amgen Inc
2. AstraZeneca
3. Bayer AG
4. Bristol-Myers Squibb Company
5. Pfizer Inc
6. Novarts AG
7. Johnson & Johnson
8. Eli Lily Company
9. F. Hoffmann-la Roche Ltd
10. Seattle Genetics Inc